Pfizer refused to serialize its SARS-CoV-2 injections, even though it was a legal requirement
What is Serialization?
Serialization is a mandatory requirement in the pharmaceutical industry. It was introduced in order to protect against counterfeit or other misbranded products entering the legitimate supply chain.
This article, Serialization in the Pharmaceutical Industry, provides useful information, including this extract:
The precondition for protection against counterfeit medicines is to produce a barcode (2d data matrix) that gives all production data (GTIN [Global Trade Item Number], expiration date, lot number) for one unit medicine. This distinctive marking ensures the authenticity and integrity of the medicine so that the manufacturer ensures that all the medicines are protected from intervention.”
Note the reference to one unit medicine. This means that the manufacturer must apply a 2D barcode to every unit of finished product produced and upload their manufacturing information to a central database. As the product moves through the distribution to patients, the barcode can be scanned and checked for authenticity, or not.
A subscriber made the connection
I was aware that this could not have happened with the Pfizer and Moderna vaccines, because they left the manufacturer frozen and in vials containing 5 doses, not a single dose. What I didn’t know was this comment in the Newsletter below, from a subscriber
““Curious to note the leaked Pfizer contract(s) state "the Participating Member State acknowledges that the Vaccine shall not be serialized."“
Read more here, or skip on:
FDA definition of batch and batch number
Now we need to go onto FDA definitions:
Batch means a specific quantity of a drug or other material that is intended to have uniform character and quality, within specified limits, and is produced according to a single manufacturing order during the same cycle of manufacture.
Lot number, control number, or batch number means any distinctive combination of letters, numbers, or symbols, or any combination of them, from which the complete history of the manufacture, processing, packing, holding, and distribution of a batch or lot of drug product or other material can be determined.
Hedley explains with the help of wallpaper (recording):
The mRNA vaccines were only part-finished, and not unit doses, when they left the manufacturer, so could not have been serialized. They also had to bypass the long-established wholesale distribution networks in the various countries, because they were not geared up for frozen or ultra-frozen temperatures. These wholesale distributors must have licenses, based on compliance with Good Distribution Practice (GDP), before they are allowed to operate. This all amounts to gross non-compliance with safe working practices, in place to keep patients safe from errors and malintent.